We also determined that sGCα1 serves a pro-survival function in prostate cancer by inhibiting p53 activity and selectively suppressing genes that are involved in apoptosis, via a mechanism of p53 cytoplasmic sequestration [20]. The gene discussed is TP53; the disease is prostate carcinoma.